Pipeline

Advancing Novel T Cell Engaging Immunotherapies

Harpoon is a clinical-stage immuno-oncology company building a pipeline of wholly-owned immunotherapies harnessing the tumor-killing power of T cells for patients with difficult-to-treat tumors.

PSMA
Prostate Cancer
    
MSLN
Ovarian Cancer & Other Solid Tumors
    
BCMA
Multiple Myeloma
    
DLL3
Small Cell Lung Cancer
    
Product Candidate
Target/Indication